A previous study exploring intravitreal autologous lineage-negative BM cell therapy used this rd1 model combined with a slower model of retinal degeneration (rd10) to show a therapeutic effect of murine lineage-negative cells in slowing retinal degeneration.11 The cell therapy was administered when mice were 2 weeks of age. This evidence concerns the gene PDE6B and retinal degeneration.